Hakkı Gürsöz - Publications, H-index & Citations

Hakkı Gürsöz

ministry of health - turkey

8H指数

39论文数

239被引数

收录论文 8

发表时间

Assessment of quarter billion primary care prescriptions from a nationwide antimicrobial stewardship program

SCIENTIFIC REPORTS

IF3.9

2021-07-16

OAAI

Gonen, Mehmet; Aksoy, Mesil; Isli, Fatma; Gurpinar, Umut Emre; Gobel, Pinar; Gursoz, Hakki; Ergonul, Onder

AN ECONOMIC EVALUATION OF GENERIC DRUG ENTRIES IN TURKISH PHARMACEUTICAL MARKET

VALUE IN HEALTH

IF6

2018-10-01

OAAI

Bektemur, G.; Yilmaz, Safak E.; Atikeler, K.; Vural, I. M.; Nacar, S.; Beyan, A.; Bayar, B.; Gursoz, H.

IMPACT OF HEALTH POLICY CHANGES ON THE GROWTH LOCALLY MANUFACTURED AND IMPORTED PHARMACEUTICAL MARKETS IN TURKEY

VALUE IN HEALTH

IF6

2014-11-01

OAAI

Vural, Hilal E.; Kockaya, G.; Yenilmez, F. B.; Saylan, M.; Yilmaz, Safak E.; Tatar, M.; Vural, I. M.; Akbulat, A.; Gursoz, H.; Artiran, G.; Kerman, S.

IMPACT OF HEALTH POLICY CHANGES ON THE GROWTH LOCALLY MANUFACTURED AND IMPORTED PHARMACEUTICAL MARKETS OF TOP SELLING ATC1 PHRAMACEUTICAL GROUP (ALIMENTARY AND METABOLISM (A0) IN TURKEY

VALUE IN HEALTH

IF6

2014-11-01

OAAI

Kockaya, G.; Yenilmez, F. B.; Saylan, M.; Yilmaz, Safak E.; Tatar, M.; Vural, Hilal E.; Vural, I. M.; Akbulat, A.; Gursoz, H.; Artiran, G.; Kerman, S.

IMPACT OF HEALTH POLICY CHANGES ON THE COST SALES OF 5 TOP SELLING ATC1 PHRAMACEUTICAL GROUPS IN TURKEY

VALUE IN HEALTH

IF6

2014-11-01

OAAI

Yenilmez, F. B.; Kockaya, G.; Saylan, M.; Yilmaz, Safak E.; Tatar, M.; Vural, Hilal E.; Vural, I. M.; Akbulat, A.; Gursoz, H.; Artiran, G.; Kerman, S.

OFF-LABEL TRASTUZUMAB USAGE IN BREAST CANCER PATIENT IN TURKEY

VALUE IN HEALTH

IF6

2013-11-01

OAAI

Kockaya, G.; Tanyeri, P.; Buyukokuroglu, M. E.; Yenilmez, F. B.; Durmus, D.; Vural, I. M.; Akbulat, A.; Artiran, G.; Gursoz, H.; Kerman, S.

AN OVERVIEW OF DOMESTIC CANCER DRUGS IN TURKEY: 2008-2012

VALUE IN HEALTH

IF6

2013-11-01

OAAI

Vural, E. H.; Safak, Yilmaz E.; Vural, I. M.; Dogan, E.; Akbulat, A.; Gursoz, H.; Kerman, S.